# Medical Treatment for Diamond Blackfan Anemia

> **NCT00001749** · PHASE2 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 25 (—)

## Conditions studied

- Fanconi's Anemia
- Hematologic Disease

## Interventions

- **DRUG:** Antithymocyte globulin
- **DRUG:** Cyclosporine

## Key facts

- **NCT ID:** NCT00001749
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-07
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 25 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001749, "Medical Treatment for Diamond Blackfan Anemia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00001749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*